Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Shrinking team NBB
FTE fell two years in a row, from 1.9 to 1.4.
Financials
Financial year 2025
b.clinic from Brussel, company number BE0695864340, closed financial year 2025 with a result of € -41,628 after tax. For that financial year b.clinic recorded a gross margin of € 67,422 and equity of € -551,183. Compared with financial year 2024, the result moved from € 11,954 to € -41,628. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.
€ -551,183
▼ € 41,628 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -41,628
▼ still € 11,954 profit in 2024
Profit after tax over the fiscal year.
€ 15,684
▼ 72% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -569,783.
People and assets in 2025
1.4
▼ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 89,575
▲ 4% vs 2024
€ 64,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 6,531
▼ 60% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 7,551
▼ 19% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 73,598 | € 101,162 | € 117,627 | € 67,422 | ▼ 43% |
| Profit after taxes | € -91,560 | € -12,289 | € 11,954 | € -41,628 | ▼ € 53,582 |
| Equity | € -509,220 | € -521,510 | € -509,555 | € -551,183 | ▼ € 41,628 |
| Total debts | € 626,612 | € 659,354 | € 665,048 | € 671,500 | ▲ 1% |
| Cash | € 31,658 | € 27,247 | € 55,983 | € 15,684 | ▼ 72% |
| Retained profit | € -527,820 | € -540,110 | € -528,155 | € -569,783 | ▼ € 41,628 |
| Balance sheet total | € 117,391 | € 137,844 | € 155,493 | € 120,317 | ▼ 23% |
| Employees (FTE) | 3.4 | 1.9 | 1.6 | 1.4 | ▼ 0.2 |
Key figures of b.clinic, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to b.clinic?
What happened at b.clinic in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 41,628 (▼ € 53,582 vs 2024). Source: NBB ↗
- New establishment in Brussel. KBO
- New establishment in Gent. KBO
- Charles-Eric Winandy became a director. NBB
- Philippe Van Overschelde became a director. NBB
- Ward Servaes became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 91,560 loss in 2022 to € 41,628 loss in 2025.
Paid € 55 in corporate taxes since 2022.
Best year ever: 2024, with € 11,954 profit.
On average € 48,200 of value added per employee in 2025.
A new publication or filing at b.clinic? We notify you, reason included.
Follow b.clinicDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of MoveUP comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
b.clinicBehind b.clinic are Charles-Eric Winandy, Philippe Van Overschelde and Ward Servaes. The shares are held by MoveUP (100%).
Directors
According to the 2025 annual accounts
Philippe Van Overschelde
Director
Also active at: SCALDINO, ORTHOPEDIST DR. VAN OVERSCHELDE HIP KNEE CLINIC DEURLE, CN Concepts, HKC DEURLE, MOG
since 2018
Ward Servaes
Director
since 2018
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Kantersteen 47
1000 Brussel
Kliniekstraat 27
9050 Gent
Active since 9 May 2018
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0695.864.340
- VAT number
- BE 0695.864.340
- Registered office
- Kantersteen 47, 1000 Brussel
- Names & denominations
- b.clinic
- Enterprise type
- Rechtspersoon
- Legal form
- Cooperative company
- Legal situation
- Normale toestand
- Start date
- 9 May 2018
- Peppol
- Active · Active since 11 Aug 2026
- Activities · NACE
Andere ambulante revalidatieactiviteiten
Ambulante revalidatieactiviteiten